ReviewCancers2026

The Great Debate: CAR-T-Cell Therapy Versus Bispecific Antibodies in B-Cell Lymphoma.

Massimo Martino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.